| 2026-02-20 | +52.9% | news | Seeking Alpha | Tandem Diabetes Care targets 10-11% pump shipment growth in 2026 with PayGo transition |
| 2026-02-20 | +52.9% | earnings | Seeking Alpha | Tandem Diabetes Care, Inc. (TNDM) Q4 2025 Earnings Call Transcript |
| 2026-02-20 | +52.9% | earnings | Seeking Alpha | Tandem Diabetes Care, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-20 | +52.9% | news | The Motley Fool | Why Tandem Diabetes Care Stock Popped Today - The Motley Fool |
| 2026-02-20 | +52.9% | news | Yahoo Finance | Why Tandem Diabetes Care Stock Popped Today - Yahoo Finance |
| 2026-02-20 | +52.9% | news | Yahoo Finance | Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance |
| 2026-02-20 | +52.9% | earnings | Yahoo Finance | TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up - Yahoo Finance |
| 2026-02-20 | +52.9% | analyst | Investing.com | Mizuho raises Tandem Diabetes stock price target on pump shipments - Investing.com |
| 2026-02-20 | +52.9% | earnings | Stocktwits | Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - Stocktwits |
| 2026-02-20 | +52.9% | earnings | TradingView | TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up - TradingView |
| 2026-02-20 | +52.9% | news | TradingView | Why Are Tandem Diabetes (TNDM) Shares Soaring Today - TradingView |
| 2026-02-20 | +52.9% | analyst | Investing.com | BofA upgrades Tandem Diabetes stock rating on business model shift - Investing.com |
| 2026-02-20 | +52.9% | earnings | Zacks Investment Research | TNDM Q4 Earnings & Revenues Beat Estimates, Gross Margin & Stock Up - Zacks Investment Research |
| 2025-02-26 | -33.2% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2022-11-02 | -30.8% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | +29.3% | earnings | Seeking Alpha | Tandem Diabetes rises following Q4 earnings beats |
| 2026-02-19 | +29.3% | earnings | Seeking Alpha | Tandem Diabetes Care GAAP EPS of -$0.01 beats by $0.05, revenue of $290.4M beats by $13.16M |
| 2026-02-19 | +29.3% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-02-19 | +29.3% | earnings | Drug Delivery Business | Tandem stock rises on Q4 beats, new pay-as-you-go model - Drug Delivery Business |
| 2026-02-19 | +29.3% | earnings | Yahoo Finance | Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2026-02-19 | +29.3% | earnings | Yahoo Finance | Tandem Diabetes Care (TNDM) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance |
| 2026-02-19 | +29.3% | earnings | Investing.com | Tandem Diabetes Care earnings beat by $0.08, revenue topped estimates - Investing.com |
| 2026-02-19 | +29.3% | earnings | MassDevice | Tandem stock rises on Q4 beats, new pay-as-you-go model - MassDevice |
| 2026-02-19 | +29.3% | earnings | TradingView | Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates - TradingView |
| 2026-02-19 | +29.3% | earnings | ChartMill | Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Strong Q4 Beat but Issues Cautious 2026 Sales Guidance - ChartMill |
| 2026-02-19 | +29.3% | earnings | GuruFocus | Tandem Diabetes Care (TNDM) Surges 5% After Beating Q4 Expectati - GuruFocus |
| 2025-08-06 | -24.6% | earnings | Seeking Alpha | Tandem Diabetes Care GAAP EPS of -$0.78 misses by $0.38, revenue of $240.7M beats by $2.31M |
| 2025-08-06 | -24.6% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2025-08-06 | -24.6% | earnings | Quiver Quantitative | TANDEM DIABETES CARE Earnings Results: $TNDM Reports Quarterly Earnings - Quiver Quantitative |
| 2025-08-06 | -24.6% | earnings | Yahoo Finance | Tandem Diabetes (NASDAQ:TNDM) Exceeds Q2 Expectations But Stock Drops 17% - Yahoo Finance |
| 2025-08-06 | -24.6% | earnings | Drug Delivery Business | Tandem Diabetes Care posts Q2 sales beat, expects $1B in revenue for 2025 - Drug Delivery Business |
| 2023-11-13 | +22.9% | legal | SEC EDGAR | TNDM 8-K: 5.02 (SEC Filing) |
| 2025-08-07 | -22.7% | analyst | Seeking Alpha | Tandem downgraded to Neutral at Piper Sandler on softer outlook |
| 2025-08-07 | -22.7% | earnings | Seeking Alpha | Insulin pump makers Tandem and Insulet post contrasting Q2 results |
| 2025-08-07 | -22.7% | news | Seeking Alpha | Tandem Diabetes projects $1B sales for 2025 as international growth, pharmacy channel, and product innovation drive outlook |
| 2025-08-07 | -22.7% | earnings | Seeking Alpha | Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call Transcript |
| 2025-08-07 | -22.7% | legal | SEC EDGAR | TNDM 8-K: 8.01 (SEC Filing) |
| 2024-05-02 | +21.3% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2025-11-07 | +21.1% | news | Seeking Alpha | Tandem Diabetes Care outlines path to $1B sales milestone and gross margin gains in 2025 while expanding pharmacy channel |
| 2025-11-07 | +21.1% | earnings | Seeking Alpha | Tandem Diabetes Care, Inc. (TNDM) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | +21.1% | news | StockStory | Why Is Tandem Diabetes (TNDM) Stock Soaring Today - StockStory |
| 2025-11-07 | +21.1% | earnings | IndexBox | Tandem Diabetes Care Stock Jumps on Q3 Earnings Beat | TNDM News - News and Statistics - IndexBox |
| 2025-04-30 | +18.4% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-02-21 | +16.0% | earnings | Trefis | Tandem Diabetes (+33%) : Record Margins & Revenue Beat Ignites Squeeze - Trefis |
| 2024-08-01 | +15.9% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2022-05-04 | -15.8% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2022-08-03 | -15.5% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2023-11-01 | -15.1% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-03-27 | -14.0% | news | StockStory | Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know |
| 2026-03-27 | -14.0% | news | Stock Titan | [SCHEDULE 13G/A] TANDEM DIABETES CARE INC Amended Passive Investment Disclosure - Stock Titan |
| 2026-03-27 | -14.0% | news | StockStory | Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - StockStory |
| 2025-11-06 | +11.8% | earnings | Seeking Alpha | Tandem Diabetes Care soars after double Q3 beats |
| 2025-11-06 | +11.8% | earnings | Seeking Alpha | Tandem Diabetes Care GAAP EPS of -$0.31 beats by $0.05, revenue of $249.25M beats by $13.48M |
| 2025-11-06 | +11.8% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | +11.8% | earnings | Yahoo Finance | Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance |
| 2025-11-06 | +11.8% | earnings | Drug Delivery Business | Tandem stock rises after hours on Q3 beats, record sales - Drug Delivery Business |
| 2025-11-06 | +11.8% | news | Yahoo Finance | Why Tandem Diabetes (TNDM) Shares Are Plunging Today - Yahoo Finance |
| 2025-11-06 | +11.8% | earnings | MassDevice | Tandem stock rises after hours on Q3 beats, record sales - MassDevice |
| 2025-11-06 | +11.8% | news | StockStory | Why Tandem Diabetes (TNDM) Shares Are Plunging Today - StockStory |
| 2025-11-06 | +11.8% | news | BioSpace | Tandem Diabetes Care Announces Third Quarter 2025 Financial Results - BioSpace |
| 2025-11-06 | +11.8% | earnings | StockStory | Tandem Diabetes (NASDAQ:TNDM) Beats Expectations in Strong Q3, Stock Jumps 17.5% - StockStory |
| 2025-11-05 | -11.6% | earnings | Seeking Alpha | Tandem Diabetes Care Q3 2025 Earnings Preview |
| 2026-03-30 | -11.3% | news | simplywall.st | Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - simplywall.st |
| 2026-03-17 | +10.0% | analyst | Seeking Alpha | Tandem rises as Piper Sandler upgrades on pharmacy strategy |
| 2026-03-17 | +10.0% | news | Yahoo Finance | Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance |
| 2026-03-17 | +10.0% | analyst | Seeking Alpha | Tandem rises as Piper Sandler upgrades on pharmacy strategy - Seeking Alpha |
| 2026-03-17 | +10.0% | news | Benzinga | Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga |
| 2026-02-23 | +9.8% | news | Seeking Alpha | Tandem Diabetes Care announces proposed private placement of convertible notes |
| 2026-02-23 | +9.8% | earnings | Seeking Alpha | Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition |
| 2026-02-23 | +9.8% | news | Yahoo Finance | Here’s Why The Brown Capital Management Small Company Fund Sold Tandem Diabetes Care (TNDM) - Yahoo Finance |
| 2026-02-23 | +9.8% | news | Drug Delivery Business | Tandem Diabetes Care announces $200M notes offering - Drug Delivery Business |
| 2026-02-23 | +9.8% | analyst | Investing.com | Truist raises Tandem Diabetes stock price target on pharmacy shift - Investing.com |
| 2026-02-23 | +9.8% | news | Business Wire | Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes - Business Wire |
| 2026-02-23 | +9.8% | earnings | Seeking Alpha | Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition (NASDAQ:TNDM) - Seeking Alpha |
| 2026-02-23 | +9.8% | news | Investing.com | Tandem Diabetes stock falls on $200M convertible debt offering - Investing.com |
| 2026-02-23 | +9.8% | news | Investing.com | Tandem Diabetes plans $200M convertible notes offering - Investing.com |
| 2026-02-23 | +9.8% | analyst | Investing.com | Tandem Diabetes stock rating upgraded by Lake Street on pharmacy shift - Investing.com |
| 2026-02-23 | +9.8% | analyst | GuruFocus | Lake Street Upgrades Tandem Diabetes Care (TNDM) to 'Buy', Sets Price Target at $50 | TNDM Stock News - GuruFocus |
| 2025-08-10 | -9.7% | earnings | Seeking Alpha | Tandem Diabetes Care: An Earnings Miss Confirms The Bear Case - Downgrade To Sell |
| 2025-08-10 | -9.7% | earnings | Seeking Alpha | Tandem Diabetes Care: Earnings Miss Confirms Bear Case - Downgrade To Sell (NASDAQ:TNDM) - Seeking Alpha |
| 2023-01-10 | -8.9% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2025-08-12 | +8.6% | analyst | Seeking Alpha | Tandem Diabetes upgraded at Citi on risk-reward setup |
| 2025-11-21 | +7.6% | news | FinancialContent | 2 Momentum Stocks with Solid Fundamentals and 1 We Turn Down - FinancialContent |
| 2025-08-05 | -6.9% | earnings | Seeking Alpha | Tandem Diabetes Care Q2 2025 Earnings Preview |
| 2025-12-12 | +6.7% | news | The Motley Fool | Don't Buy Tandem Diabetes Care Until This Big Thing Happens - The Motley Fool |
| 2021-05-05 | -6.5% | legal | SEC EDGAR | TNDM 8-K: 2.02 (SEC Filing) |
| 2026-03-29 | -6.4% | legal | Stock Titan | TNDM SEC Filings - Tandem Diabetes 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-06-10 | +6.2% | M&A | Seeking Alpha | Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor |
| 2022-12-13 | -6.2% | legal | SEC EDGAR | TNDM 8-K: 1.01 (SEC Filing) |
| 2026-03-19 | +6.0% | analyst | MT Newswires | Tandem Diabetes Care Shares Rise After Truist Upgrade |
| 2026-03-19 | +6.0% | news | StockStory | 3 Reasons to Sell TNDM and 1 Stock to Buy Instead |
| 2026-03-19 | +6.0% | analyst | Seeking Alpha | Tandem gains as Truist becomes latest to upgrade on new pharmacy model |
| 2026-03-19 | +6.0% | analyst | Seeking Alpha | Tandem upgraded at Truist on pharmacy model (TNDM:NASDAQ) - Seeking Alpha |
| 2025-11-10 | +6.0% | legal | Stock Titan | Tandem Diabetes (NASDAQ: TNDM) receives FDA clearance for Mobi Android app, early 2026 - Stock Titan |
| 2021-11-03 | -6.0% | legal | SEC EDGAR | TNDM 8-K: 2.02 (SEC Filing) |
| 2022-02-16 | -5.8% | legal | SEC EDGAR | TNDM 8-K: 8.01 (SEC Filing) |
| 2026-03-02 | -5.3% | news | San Diego Business Journal | Tandem Bests $1B Worldwide Sales - San Diego Business Journal |
| 2024-06-21 | -5.3% | legal | SEC EDGAR | TNDM 8-K: 5.02 (SEC Filing) |
| 2025-09-25 | -5.2% | news | Yahoo Finance | Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today - Yahoo Finance |
| 2025-12-03 | +5.1% | news | StockStory | Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know - StockStory |
| 2025-11-25 | -5.1% | news | DirectorsTalk Interviews | Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovations - DirectorsTalk Interviews |
| 2026-03-04 | -4.8% | news | Stock Titan | Tiny insulin pump now runs from Android phones for more diabetes control - Stock Titan |
| 2026-03-04 | -4.8% | M&A | simplywall.st | Tandem Diabetes Care Bond Deal Reshapes Funding And Valuation Picture - simplywall.st |
| 2025-11-13 | +4.7% | legal | Yahoo Finance | Tandem Diabetes Care (TNDM) Is Up 23.1% After FDA Clears Android App for Mobi System – Has the Bull Case Changed? - Yahoo Finance |
| 2026-04-17 | +4.7% | executive | Stock Titan | Tandem Diabetes (TNDM) COO exercises RSUs; shares withheld for taxes - Stock Titan |
| 2025-12-04 | +4.7% | analyst | Investor's Business Daily | Tandem Diabetes Care Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily |
| 2026-03-18 | +4.6% | news | Yahoo Finance | Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - Yahoo Finance |
| 2026-03-18 | +4.6% | analyst | Investing.com South Africa | Truist upgrades Tandem Diabetes Care stock rating on Pay/Go model By Investing.com - Investing.com South Africa |
| 2026-03-18 | +4.6% | news | Stock Titan | Tandem Diabetes (TNDM) EVP exercises 7,414 RSUs and sells 187 shares - Stock Titan |
| 2021-08-04 | +4.6% | legal | SEC EDGAR | TNDM 8-K: 2.02 (SEC Filing) |
| 2024-04-01 | -4.6% | legal | SEC EDGAR | TNDM 8-K: 8.01 and (SEC Filing) |
| 2026-02-25 | -4.4% | news | Seeking Alpha | Tandem Diabetes Care prices $265M convertible debt offering |
| 2026-02-25 | -4.4% | news | Business Wire | Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032 - Business Wire |
| 2023-08-18 | -4.1% | legal | SEC EDGAR | TNDM 8-K: 5.02 and (SEC Filing) |
| 2025-10-18 | +4.0% | news | Yahoo Finance | Tandem Diabetes Care (TNDM) Is Up 5.6% After Pump Correction Spurs Legal Scrutiny and Insider Buying – Has the Bull Case Changed? - Yahoo Finance |
| 2024-02-21 | +4.0% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2023-01-23 | -3.7% | legal | SEC EDGAR | TNDM 8-K: 2.01 and (SEC Filing) |
| 2026-03-25 | -3.6% | news | StockStory | 3 Small-Cap Stocks That Concern Us |
| 2024-03-11 | -3.6% | legal | SEC EDGAR | TNDM 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2023-08-03 | +3.5% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2025-12-14 | +3.5% | news | Yahoo Finance | Does Tandem Diabetes Care’s Slumping Share Price Signal a New Opportunity in 2025? - Yahoo Finance |
| 2025-06-16 | -3.4% | news | Seeking Alpha | Truist bullish on diabetes companies citing potential market growth |
| 2025-12-02 | -3.4% | news | Yahoo Finance | Assessing Tandem Diabetes Care’s (TNDM) Valuation After Legal Probe and t:slim X2 Pump Correction Announcement - Yahoo Finance |
| 2025-05-12 | -3.3% | legal | SEC EDGAR | TNDM 8-K: 8.01 (SEC Filing) |
| 2025-11-04 | +3.0% | earnings | TradingView | Tandem Diabetes Earnings: What To Look For From TNDM - TradingView |
| 2025-11-04 | +3.0% | earnings | StockStory | Tandem Diabetes Earnings: What To Look For From TNDM - StockStory |
| 2025-12-18 | -2.9% | earnings | Yahoo Finance | Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks - Yahoo Finance |
| 2025-12-18 | -2.9% | news | Stock Titan | New app lets Canadians manage insulin pump directly from their phone - Stock Titan |
| 2022-03-15 | +2.9% | legal | SEC EDGAR | TNDM 8-K: 5.02 (SEC Filing) |
| 2025-12-16 | +2.8% | analyst | Seeking Alpha | Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 |
| 2025-05-20 | -2.7% | legal | SEC EDGAR | TNDM 8-K: 8.01 (SEC Filing) |
| 2023-11-06 | +2.7% | legal | SEC EDGAR | TNDM 8-K: 8.01 (SEC Filing) |
| 2025-05-23 | +2.7% | legal | SEC EDGAR | TNDM 8-K: 1.01 and 5.07 (SEC Filing) |
| 2024-11-06 | -2.6% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | +2.6% | news | GuruFocus | Tandem Diabetes Care Inc (TNDM) Stock Up 3.7% and Still Underval - GuruFocus |
| 2025-08-14 | -2.6% | news | Investing.com | Tandem Diabetes Care’s SWOT analysis: stock faces challenges amid competitive pressures - Investing.com |
| 2026-04-04 | +2.5% | news | Simply Wall St. | Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness |
| 2026-04-04 | +2.5% | news | Yahoo Finance | Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance |
| 2026-04-03 | +2.5% | news | Trefis | Tandem Diabetes Care Stock Slides -26% With A 8-Day Losing Spree - Trefis |
| 2022-02-22 | +2.5% | legal | SEC EDGAR | TNDM 8-K: 2.02 and 5.02 (SEC Filing) |
| 2023-02-22 | -2.5% | legal | SEC EDGAR | TNDM 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-04-21 | -2.5% | news | GlobeNewswire | Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed |
| 2026-04-21 | -2.5% | news | GuruFocus | A Look at Tandem Diabetes Care Inc (TNDM) After 3.0% Gain -- GF Value $33.02 vs Price $21.24 - GuruFocus |
| 2026-04-23 | -2.4% | news | GlobeNewswire | Global Automated Insulin Delivery System Market Size/Share Worth USD 2684 Million by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) |
| 2026-04-23 | -2.4% | analyst | MSN | B of A Securities upgrades Tandem Diabetes Care (TNDM) - MSN |
| 2025-10-29 | -2.3% | news | simplywall.st | Market Might Still Lack Some Conviction On Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Even After 26% Share Price Boost - simplywall.st |
| 2022-06-16 | +2.2% | legal | SEC EDGAR | TNDM 8-K: 5.02 (SEC Filing) |
| 2021-09-17 | +2.2% | legal | SEC EDGAR | TNDM 8-K: 1.01 (SEC Filing) |
| 2023-12-11 | -2.1% | legal | SEC EDGAR | TNDM 8-K: 5.02 (SEC Filing) |
| 2025-10-31 | -2.1% | news | Yahoo Finance | Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today - Yahoo Finance |
| 2025-10-31 | -2.1% | news | TradingView | Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today - TradingView |
| 2025-08-11 | -2.0% | earnings | Yahoo Finance | TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up - Yahoo Finance |
| 2026-02-18 | -1.9% | earnings | Seeking Alpha | Tandem Diabetes Care Q4 2025 Earnings Preview |
| 2026-02-18 | -1.9% | news | Yahoo Finance | Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance |
| 2026-01-11 | -1.8% | news | Yahoo Finance | Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued? - Yahoo Finance |
| 2026-02-27 | -1.7% | legal | SEC EDGAR | TNDM 8-K: 1.01, 2.03, 3.02, 8.01 (SEC Filing) |
| 2026-02-26 | -1.7% | news | Seeking Alpha | Tandem Diabetes Care, Inc. (TNDM) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript |
| 2025-11-12 | +1.7% | legal | SEC EDGAR | TNDM 8-K: 5.02 and (SEC Filing) |
| 2025-11-12 | +1.7% | news | Stock Titan | Tandem (NASDAQ: TNDM) names Sandra Beaver as independent director to its board - Stock Titan |
| 2026-04-07 | -1.7% | news | StockStory | 3 Stocks Under $50 Walking a Fine Line |
| 2026-04-07 | -1.7% | news | simplywall.st | The Bull Case For Tandem Diabetes Care (TNDM) Could Change Following JPMorgan’s Stake Cut And Ongoing Selloff - simplywall.st |
| 2026-04-07 | -1.7% | news | Stock Titan | Tandem Diabetes Care (NASDAQ: TNDM) seeks approval for equity plan, charter changes - Stock Titan |
| 2023-05-03 | -1.5% | legal | SEC EDGAR | TNDM 8-K: 2.02 and (SEC Filing) |
| 2026-04-09 | -1.4% | analyst | GuruFocus | Goldman Sachs Lowers Price Target for Tandem Diabetes Care (TNDM) to $25 | TNDM Stock News - GuruFocus |
| 2025-06-20 | -1.4% | news | Seeking Alpha | Tandem's t:slim X2 insulin pump works with Abbotts FreeStyle Libre |
| 2026-04-02 | +1.4% | news | Business Wire | Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-02 | +1.4% | earnings | Stock Titan | Tandem Diabetes schedules May 7 earnings call, webcast at 4:30 p.m. ET - Stock Titan |
| 2026-04-02 | +1.4% | news | Trefis | Tandem Diabetes Care Stock In Shambles: Down 25% With 7-Day Losing Streak - Trefis |
| 2026-04-02 | +1.4% | news | Trefis | Tandem Diabetes Care Stock Plummets 26% With 8-Day Losing Streak - Trefis |
| 2026-04-02 | +1.4% | news | simplywall.st | Is It Time To Revisit Tandem Diabetes Care (TNDM) After Recent Share Price Weakness? - simplywall.st |
| 2025-10-28 | +1.1% | news | TradingView | Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know - TradingView |
| 2024-06-18 | -1.0% | legal | SEC EDGAR | TNDM 8-K: 1.01 (SEC Filing) |
| 2026-04-14 | +0.8% | analyst | Investor's Business Daily | Stocks Generating Improved Relative Strength: Tandem Diabetes Care - Investor's Business Daily |
| 2024-05-23 | +0.7% | legal | SEC EDGAR | TNDM 8-K: 5.02 and 5.07 (SEC Filing) |
| 2026-02-17 | -0.7% | earnings | Yahoo Finance | Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance |
| 2026-02-17 | -0.7% | news | DirectorsTalk Interviews | Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring A 37.96% Potential Upside - DirectorsTalk Interviews |
| 2025-09-10 | +0.7% | news | Seeking Alpha | Tandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2025-12-25 | -0.6% | news | Yahoo Finance | Is Tandem Diabetes Care (TNDM) Still Undervalued After Its Recent Share Price Rebound? - Yahoo Finance |
| 2026-02-01 | +0.5% | news | Yahoo Finance | Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? - Yahoo Finance |
| 2026-03-15 | +0.5% | news | Yahoo Finance | How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones - Yahoo Finance |
| 2026-03-15 | +0.5% | news | StockStory | 1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges - StockStory |
| 2024-05-16 | -0.1% | legal | SEC EDGAR | TNDM 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-03-22 | +0.0% | expansion | MarketBeat | Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch |